First in human clinical trial of a next generation, long-acting injectable, combination anti-retroviral therapy platform. This study will look at drug levels in the blood over time and the safety of a single injection of a new investigational medicine that combines existing short-acting oral drugs...
The purpose of this study is to understand whether HIV medications can produce inflammation in the intestine (“your gut”) and affect the size of the HIV reservoir in people living with HIV. There are two study visits: General health assessment and medical history Endoscopy and biopsies from both...
This study is designed to help us understand how the use of a mobile app (LetSync) developed for couples can improve HIV healthcare outcomes. We are asking BIPOC couples assigned male at birth and living with HIV to use the app over the 8 month...
[box class="summary"][/box]Could cannabis help us treat HIV? Despite being undetectable, people living with HIV have ongoing inflammation, which is the body’s reaction to infection, a state where some of your immune cells remain constantly activated. As well, HIV damages the lining of your intestines soon after infection....
[box class="summary"][/box]The Seattle HIV Vaccine Trials Unit is looking for volunteers to participate in studies to help find a vaccine to prevent HIV. We hope to evaluate vaccine candidates for safety and the ability to stimulate immune responses in participants. The ideal vaccine for global...
